Ophthalmology
Cataract surgery: both eyes on the same day or on different days?
24 Jun, 2022 | 10:55h | UTCCataract surgery: both eyes on the same day or on different days? – Evidently Cochrane
Original Study: Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts – Cochrane Library
Systematic Review: Rituximab for thyroid‐associated ophthalmopathy.
20 Jun, 2022 | 01:16h | UTCRituximab for thyroid‐associated ophthalmopathy – Cochrane Library
Does this patient with acute infectious conjunctivitis have a bacterial infection? The rational clinical examination systematic review.
17 Jun, 2022 | 11:12h | UTCDoes This Patient With Acute Infectious Conjunctivitis Have a Bacterial Infection? The Rational Clinical Examination Systematic Review – JAMA (free for a limited period)
Commentary on Twitter
In this review, bacterial conjunctivitis was more common than viral conjunctivitis in children and viral conjunctivitis was more common than bacterial conjunctivitis in adults, although the prevalence estimates were based on limited evidence. https://t.co/wJ6YXxPRem
— JAMA (@JAMA_current) June 16, 2022
Systematic Review: Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension.
15 Jun, 2022 | 10:30h | UTCRho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension – Cochrane Library
Summary: Rho kinase inhibitors for primary open-angle glaucoma and ocular hypertension – Cochrane Library
Systematic Review: Impact of vision impairment and ocular morbidity and their treatment on depression and anxiety in children.
14 Jun, 2022 | 10:34h | UTCCommentary: Vision Impairment Associated with Greater Depression, Anxiety in Children – HCP Live
RCT: Marine Omega-3 Fatty acid supplementation does not reduce the incidence of dry eye disease in healthy adults.
10 Jun, 2022 | 12:25h | UTCEfficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial – JAMA Ophthalmology (free for a limited period)
Invited Commentary: Another Disappointment for ω-3 Fatty Acid and Dry Eye Disease – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
In this randomized clinical trial, daily supplementation with marine omega-3 fatty acids (1 gram) for a median of 5.3 years had no significant effect on the incidence of diagnosed #dryeyedisease (DED) or reported DED symptoms. https://t.co/iTBONh6CZK
— JAMAOphthalmology (@JAMAOphth) June 9, 2022
Systematic Review: Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
8 Jun, 2022 | 10:57h | UTC
Association between retinal layer thickness and cognitive decline in older adults.
1 Jun, 2022 | 11:13h | UTCCommentaries:
Retinal Layer Thickness Linked to Risk of Cognitive Decline – NeurologyToday
Retinal Layer Thickness Linked to Cognitive Decline in Older Adults – HealthDay
Commentary on Twitter
The thickness of macular retinal nerve fiber layers could be a prognostic biomarker of long-term #cognitivedecline in adults ages 60 or older, says @JAMAOphth study. #neurotwitter @AANMember #neurology https://t.co/gKzIEfzimX pic.twitter.com/6uwwS5gmEC
— Neurology Today (@NeurologyToday) May 31, 2022
Systematic Review: Antibiotic prophylaxis for corneal abrasion.
1 Jun, 2022 | 11:06h | UTCAntibiotic prophylaxis for corneal abrasion – Cochrane Library
WHO launches new guide on integrating eye care in health systems.
30 May, 2022 | 11:48h | UTCNews Release: WHO launches new guide on integrating eye care in health systems – World Health Organization
WHO Guidance: Eye care in health systems: guide for action – World Health Organization
Review: Trachoma.
30 May, 2022 | 10:47h | UTCTrachoma – Nature Reviews Disease Primer (if the link is paywalled, try this one)
Infographic: Trachoma – Nature Reviews Disease Primer (if the link is paywalled, try this one)
Commentaries on Twitter
Get Primed on Trachoma with our NEW PrimeView! FREE to download this week! https://t.co/ZfHgLWXfHI pic.twitter.com/aUzsJRSi4J
— Nature Reviews Disease Primers (@DiseasePrimers) May 26, 2022
Our NEW Primer on Trachoma is live today! By @anthonywsolomon @matthewburton70 @EmilyGower6 @ehardingesch @CatieOldenburg @profhughrt and Traoré – @proctorfndn @LSHTM @ICEH_LSHTM @UNCpublichealth. Check it out here: https://t.co/fpIczbGILH
— Nature Reviews Disease Primers (@DiseasePrimers) May 26, 2022
Adverse effects and Safety in Glaucoma Patients – Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD) – A Delphi Consensus Statement.
26 May, 2022 | 10:14h | UTC
USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for primary open-angle glaucoma in adults.
25 May, 2022 | 11:46h | UTCEditorials:
Identifying Glaucoma in Primary Care Offices – JAMA Ophthalmology
Evidence Report: Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Patient Page: Screening for Primary Open-Angle Glaucoma – JAMA
Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults
USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for impaired visual acuity in older adults.
25 May, 2022 | 11:44h | UTCEditorials:
Visual Acuity Screening in Older Adults – JAMA Ophthalmology
Screening for Impaired Visual Acuity in Older Adults – JAMA
Evidence Report: Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Patient Page: Screening for Impaired Visual Acuity in Older Adults – JAMA
Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults – JAMA
M-A: The global prevalence of amblyopia in children.
24 May, 2022 | 07:29h | UTC
Network meta-analysis of different intravenous glucocorticoid regimes for the treatment of Graves’ orbitopathy.
20 May, 2022 | 10:34h | UTC
Artificial intelligence for screening of multiple retinal and optic nerve diseases.
9 May, 2022 | 01:18h | UTC
Commentary on Twitter
This diagnostic study developed and prospectively validated a #DeepLearning algorithm to recognize multiple retinal diseases, with better accuracy vs retinal specialists, and may help to overcome the lack of ophthalmologists in underdeveloped areas. https://t.co/9fvwOTVV8N
— JAMA Network Open (@JAMANetworkOpen) May 3, 2022
Advancing the Sustainable Development Goals through improving eye health: a scoping review.
5 May, 2022 | 10:01h | UTC
Current Guidelines on management of amaurosis fugax and transient ischemic attacks.
5 May, 2022 | 09:50h | UTC
Systematic Review: Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts.
26 Apr, 2022 | 07:52h | UTC
Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease.
21 Apr, 2022 | 09:54h | UTCRetinal age gap as a predictive biomarker of future risk of Parkinson’s disease – Age and Ageing
Related: Retinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)
Cohort Study: Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis.
18 Apr, 2022 | 10:34h | UTCCommentaries:
COVID-19 Diagnosis and Incidence of Retinal Thromboembolism – JAMA Ophthalmology
Threatening Eye Condition Rare After COVID Infection – HealthDay
Cohort Study: Use of Phosphodiesterase 5 Inhibitors linked to increased risk of ocular adverse events.
8 Apr, 2022 | 11:04h | UTCRisk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US – JAMA Ophthalmology (free for a limited period)
News Release: U.S. insurance claims show strong link between ED medications and vision problems – University of British Columbia
Commentaries:
Phase 4 Studies on Phosphodiesterase 5 Inhibitors – JAMA Ophthalmology (free for a limited period)
Could Viagra, Cialis Raise Men’s Odds for Eye Trouble? – HealthDay
Study Commentary | Advanced glaucoma: surgery lowers pressure in the eye more effectively than eye drops.
8 Apr, 2022 | 10:06h | UTC
Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.
7 Apr, 2022 | 08:18h | UTC